Madrigal Pharmaceuticals (MDGL) PT Raised to $443 at Citizens JMP

February 27, 2025 4:26 AM

Citizens JMP analyst Jonathan Wolleben raised the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $443.00 (from $427.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found